Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal

Brain Research

Volumn 1143, Issue 1, 2007, Pages 208-220

  Marcellino, Daniel ^a,c   Roberts, David C S ^b   Navarro, Gemma ^c   Filip, Malgorzata ^d   Agnati, Luigi ^e   Lluís, Carme ^c   Franco, Rafael ^c   Fuxe, Kjell ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUTE OF PHARMACOLOGY   (Poland)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Adenosine A2A receptor; Cocaine self administration; Cocaine withdrawal; Dopamine D2 receptor; Receptor receptor interaction; Striatum

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2 RECEPTOR; RACLOPRIDE; ADENOSINE A2A RECEPTOR; COCAINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; IMMUNOBLOTTING; LIGAND BINDING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BINDING COMPETITION; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; GENETICS; MALE; METABOLISM; REINFORCEMENT; SPRAGUE DAWLEY RAT; TIME; WITHDRAWAL SYNDROME;

RATTUS NORVEGICUS;

ANIMALS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; COCAINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; NUCLEUS ACCUMBENS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TRIAZINES; TRIAZOLES; TRITIUM;

EID: 33947307050     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.079     Document Type: Article

References (62)

1. Adams J.U., Careri J.M., Efferen T.R., and Rotrosen J. Differential effects of dopamine antagonists on locomotor activity, conditioned activity and conditioned place preference induced by cocaine in rats. Behav. Pharmacol. 12 (2001) 603-611
2. Agnati L.F., Franzen O., Ferre S., Leo G., Franco R., and Fuxe K. Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. J. Neural Transm. (2003) 1-28 (Suppl.)
3. Agnati L.F., Guidolin D., Leo G., and Fuxe K. A boolean network modelling of receptor mosaics. Relevance of topology and cooperativity. J. Neural Transm. 114 (2007) 77-92
4. Anden N.E., Dahlström A., Larsson K., Olson L., and Ungerstedt U. Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiol. Scand. 67 (1966) 313-326
5. Andrews C.M., and Lucki I. Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology (Berlin) 155 (2001) 221-229
6. Antonelli T., Fuxe K., Agnati L., Mazzoni E., Tanganelli S., Tomasini M.C., and Ferraro L. Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias. J. Neurol. Sci. 248 (2006) 16-22
7. Bailey A., Gianotti R., Ho A., and Kreek M.J. Persistent upregulation of mu-opioid, but not adenosine, receptors in brains of long-term withdrawn escalating dose "binge" cocaine-treated rats. Synapse 57 (2005) 160-166
8. Baldo B.A., Koob G.F., and Markou A. Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats. J. Neurosci. 19 (1999) 11017-11026
9. Ben-Shahar O., Keeley P., Cook M., Brake W., Joyce M., Nyffeler M., Heston R., and Ettenberg A. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res. 1131 (2007) 220-228
10. Blum D., Galas M.C., Pintor A., Brouillet E., Ledent C., Muller C.E., Bantubungi K., Galluzzo M., Gall D., Cuvelier L., Rolland A.S., Popoli P., and Schiffmann S.N. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. J. Neurosci. 23 (2003) 5361-5369
11. Caine S.B., Negus S.S., Mello N.K., and Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J. Pharmacol. Exp. Ther. 291 (1999) 353-360
12. Canals M., Marcellino D., Fanelli F., Ciruela F., de Benedetti P., Goldberg S.R., Neve K., Fuxe K., Agnati L.F., Woods A.S., Ferre S., Lluis C., Bouvier M., and Franco R. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 278 (2003) 46741-46749
13. Carlezon Jr. W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E.J. Regulation of cocaine reward by CREB. Science 282 (1998) 2272-2275
14. Carlisle H.J., and Kennedy M.B. Spine architecture and synaptic plasticity. Trends Neurosci. 28 (2005) 182-187
15. Chen J.F., Moratalla R., Yu L., Martin A.B., Xu K., Bastia E., Hackett E., Alberti I., and Schwarzschild M.A. Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization. Neuropsychopharmacology 28 (2003) 1086-1095
16. Chiang M.C., Lee Y.C., Huang C.L., and Chern Y. cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. J. Biol. Chem. 280 (2005) 14331-14340
17. Ferre S., Ciruela F., Woods A.S., Canals M., Burgueno J., Marcellino D., Karcz-Kubicka M., Hope B.T., Morales M., Popoli P., Goldberg S.R., Fuxe K., Lluis C., Franco R., and Agnati L. Glutamate mGluR5-adenosine A2A-dopamine D2 receptor interactions in the striatum. Implications for drug therapy in neuro-psychiatric disorders and drug abuse. Curr. Med. Chem. 3 (2003) 1-26
18. Filip M., Frankowska M., Zaniewska M., Przegalinski E., Muller C.E., Agnati L., Franco R., Roberts D.C., and Fuxe K. Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine. Brain Res. 1077 (2006) 67-80
19. Franco R., Canals M., Marcellino D., Ferre S., Agnati L., Mallol J., Casado V., Ciruela F., Fuxe K., Lluis C., and Canela E.I. Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. Trends Biochem. Sci. 28 (2003) 238-243
20. Franco R., Casado V., Mallol J., Ferre S., Fuxe K., Cortes A., Ciruela F., Lluis C., and Canela E.I. Dimer-based model for heptaspanning membrane receptors. Trends Biochem. Sci. 30 (2005) 360-366
21. Fuxe K., Agnati L.F., Jacobsen K., Hillion J., Canals M., Torvinen M., Tinner-Staines B., Staines W., Rosin D., Terasmaa A., Popoli P., Leo G., Vergoni V., Lluis C., Ciruela F., Franco R., and Ferre S. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61 (2003) S19-S23
22. Fuxe K., Ferre S., Canals M., Torvinen M., Terasmaa A., Marcellino D., Goldberg S.R., Staines W., Jacobsen K.X., Lluis C., Woods A.S., Agnati L.F., and Franco R. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J. Mol. Neurosci. 26 (2005) 209-220
23. Gimenez-Llort L., Schiffmann S.N., Shmidt T., Canela L., Camon L., Wassholm M., Canals M., Terasmaa A., Fernandez-Teruel A., Tobena A., Popova E., Ferre S., Agnati L., Ciruela F., Martinez E., Scheel-Kruger J., Lluis C., Franco R., Fuxe K., and Bader M. Working memory deficits in transgenic rats overexpressing human adenosine A(2A) receptors in the brain. Neurobiol. Learn. Mem. 87 (2007) 42-56
24. Greengard P. The neurobiology of dopamine signalling. Biosci. Rep. 21 (2001) 247-269
25. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., Hansson A., Watson S., Olah M.E., Mallol J., Canela E.I., Zoli M., Agnati L.F., Ibanez C.F., Lluis C., Franco R., Ferre S., and Fuxe K. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 277 (2002) 18091-18097
26. Jansson A., Goldstein M., Tinner B., Zoli M., Meador-Woodruff J.H., Lew J.Y., Levey A.I., Watson S., Agnati L.F., and Fuxe K. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat. Neuroscience 89 (1999) 473-489
27. Joyce J.N., and Millan M.J. Dopamine D3 receptor antagonists as therapeutic agents. Drug Discovery Today 10 (2005) 917-925
28. Justinova Z., Ferre S., Segal P.N., Antoniou K., Solinas M., Pappas L.A., Highkin J.L., Hockemeyer J., Munzar P., and Goldberg S.R. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats. J. Pharmacol. Exp. Ther. 307 (2003) 977-986
29. Kalivas P.W., Volkow N., and Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45 (2005) 647-650
30. Kita K., Shiratani T., Takenouchi K., Fukuzako H., and Takigawa M. Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats. Eur. Neuropsychopharmacol. 9 (1999) 1-7
31. Knapp C.M., Foye M.M., Cottam N., Ciraulo D.A., and Kornetsky C. Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration. Pharmacol. Biochem. Behav. 68 (2001) 797-803
32. Le Foll B., Diaz J., and Sokoloff P. A single cocaine exposure increase BDNF and D3 receptor expression: implications for drug-conditioning. NeuroReport 16 (2005) 175-178
33. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., Fischman M.W., and Laruelle M. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29 (2004) 1190-1202
34. Mattson B.J., Bossert J.M., Simmons D.E., Nozaki N., Nagarkar D., Kreuter J.D., and Hope B.T. Cocaine-induced CREB phosphorylation in nucleus accumbens of cocaine-sensitized rats is enabled by enhanced activation of extracellular signal-related kinase, but not protein kinase A. J. Neurochem. 95 (2005) 1481-1494
35. Moore R.J., Vinsant S.L., Nader M.A., Porrino L.J., and Friedman D.P. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 30 (1998) 88-96
36. Morgan D., and Roberts D.C. Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration. Neurosci. Biobehav. Rev. 27 (2004) 803-812
37. Morgan D., Brebner K., Lynch W.J., and Roberts D.C. Increases in the reinforcing efficacy of cocaine after particular histories of reinforcement. Behav. Pharmacol. 13 (2002) 389-396
38. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., Nader S.H., Buchheimer N., Ehrenkaufer R.L., and Nader M.A. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat. Neurosci. 5 (2002) 169-174
39. Nader M.A., Daunais J.B., Moore T., Nader S.H., Moore R.J., Smith H.R., Friedman D.P., and Porrino L.J. Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 27 (2002) 35-46
40. Nader M.A., Morgan D., Gage H.D., Nader S.H., Calhoun T.L., Buchheimer N., Ehrenkaufer R., and Mach R.H. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat. Neurosci. 9 (2006) 1050-1056
41. Nakata H., Yoshioka K., Kamiya T., Tsuga H., and Oyanagi K. Functions of heteromeric association between adenosine and P2Y receptors. J. Mol. Neurosci. 26 (2005) 233-238
42. 3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacoclogy 29 (2004) 1479-1487
43. Paxinos G., and Watson C. The Rat Brain Atlas in Stereotaxic Coordinates. (Vol.) (1986), Academic Press, New York
44. Robbins T.W., and Everitt B.J. Limbic-striatal memory systems and drug addiction. Neurobiol. Learn. Mem. 78 (2002) 625-636
45. Roberts D.C., and Goeders N.E. Drug self-administration: experimental methods and determinants. In: Boulton A.A., Baker G.B., and Greenshaw A.J. (Eds). Neuromethods:Psychopharmacology vol. 13 (1989), Humana Press, Clifton,NJ 349-398
46. Roberts D.C., Brebner K., Vincler M., and Lynch W.J. Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure. Drug Alcohol Depend. 67 (2002) 291-299
47. Seeman P., and Van Tol H.H. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15 (1994) 264-270
48. Segal D.M., Moraes C.T., and Mash D.C. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res. Mol. Brain Res. 45 (1997) 335-339
49. Shin E.J., Oh K.W., Kim K.W., Kwon Y.S., Jhoo J.H., Jhoo W.K., Cha J.Y., Lim Y.K., Kim I.S., and Kim H.C. Attenuation of cocaine-induced conditioned place preference by Polygala tenuifolia root extract. Life Sci. 75 (2004) 2751-2764
50. Soria G., Castane A., Ledent C., Parmentier M., Maldonado R., and Valverde O. The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. Neuropsychopharmacology 31 (2006) 978-987
51. Staley J.K., and Mash D.C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J. Neurosci. 16 (1996) 1600-6106
52. Toda S., Shen H.W., Peters J., Cagle S., and Kalivas P.W. Cocaine increases actin cycling: effects in the reinstatement model of drug seeking. J. Neurosci. 26 (2006) 1579-1587
53. Torvinen M., Kozell L.B., Neve K.A., Agnati L.F., and Fuxe K. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor. J. Mol. Neurosci. 24 (2004) 173-180
54. Torvinen M., Marcellino D., Canals M., Agnati L.F., Lluis C., Franco R., and Fuxe K. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Mol. Pharmacol. 67 (2005) 400-407
55. Tran-Nguyen L.T., Fuchs R.A., Coffey G.P., Baker D.A., and Neisewander J.L. Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19 (1998) 48-59
56. Uustare A., Vonk A., Terasmaa A., Fuxe K., and Rinken A. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors. Life Sci. 76 (2005) 1513-1526
57. Vanderschuren L.J., Di Ciano P., and Everitt B.J. Involvement of the dorsal striatum in cue-controlled cocaine seeking. J. Neurosci. 25 (2005) 8665-8670
58. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., Dewey S.L., and Wolf A.P. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14 (1993) 169-177
59. Vorel S.R., Ashby Jr. C.R., Paul M., Liu X., Hayes R., Hagan J.J., Middlemiss D.N., Stemp G., and Gardner E.L. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 22 (2002) 9595-9603
60. Vortherms T.A., and Watts V.J. Sensitization of neuronal A2A adenosine receptor after persistent D2 dopamine receptor activation. J. Pharmacol. Exp. Ther. 308 (2004) 221-227
61. Weerts E.M., and Griffiths R.R. The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons. Psychopharmacology (Berlin) 168 (2003) 155-163
62. Wong D.F., Kuwabara H., Schretlen D.J., Bonson K.R., Zhou Y., Nandi A., Brasic J.R., Kimes A.S., Maris M.A., Kumar A., Contoreggi C., Links J., Ernst M., Rousset O., Zukin S., Grace A.A., Rohde C., Jasinski D.R., Gjedde A., and London E.D. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31 (2006) 2716-2727